Citadel Advisors’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,600
| Closed | -$140K | – | 15673 |
|
|
2023
Q3 | $140K | Sell |
13,600
-1,200
| -8% | -$11.4K | ﹤0.01% | 10456 |
|
|
2023
Q2 | $122K | Buy |
14,800
+3,600
| +32% | +$21.5K | ﹤0.01% | 10627 |
|
|
2023
Q1 | $62.6K | Sell |
11,200
-2,700
| -19% | -$15.5K | ﹤0.01% | 11871 |
|
|
2022
Q4 | $68.8K | Buy |
+13,900
| New | +$57.3K | ﹤0.01% | 11722 |
|
|
2022
Q3 | – | Sell |
-21,300
| Closed | -$55K | – | 13941 |
|
|
2022
Q2 | $55K | Buy |
21,300
+5,600
| +36% | +$21K | ﹤0.01% | 11879 |
|
|
2022
Q1 | $90K | Sell |
15,700
-11,300
| -42% | -$101K | ﹤0.01% | 12386 |
|
|
2021
Q4 | $405K | Sell |
27,000
-54,300
| -67% | -$989K | ﹤0.01% | 10190 |
|
|
2021
Q3 | $2.13M | Buy |
81,300
+73,600
| +956% | +$2.71M | ﹤0.01% | 6185 |
|
|
2021
Q2 | $385K | Sell |
7,700
-8,300
| -52% | -$371K | ﹤0.01% | 10667 |
|
|
2021
Q1 | $737K | Sell |
16,000
-19,500
| -55% | -$931K | ﹤0.01% | 8832 |
|
|
2020
Q4 | $1.52M | Buy |
35,500
+12,100
| +52% | +$459K | ﹤0.01% | 5945 |
|
|
2020
Q3 | $954K | Sell |
23,400
-36,700
| -61% | -$1.83M | ﹤0.01% | 6121 |
|
|
2020
Q2 | $3.29M | Sell |
60,100
-3,100
| -5% | -$177K | ﹤0.01% | 3704 |
|
|
2020
Q1 | $3.31M | Buy |
63,200
+55,200
| +690% | +$2.99M | ﹤0.01% | 3310 |
|
|
2019
Q4 | $389K | Sell |
8,000
-5,200
| -39% | -$244K | ﹤0.01% | 7202 |
|
|
2019
Q3 | $725K | Buy |
13,200
+600
| +5% | +$34.3K | ﹤0.01% | 6141 |
|
|
2019
Q2 | $629K | Sell |
12,600
-100
| -0.8% | -$4.98K | ﹤0.01% | 6455 |
|
|
2019
Q1 | $717K | Buy |
12,700
+1,700
| +15% | +$101K | ﹤0.01% | 6178 |
|
|
2018
Q4 | $701K | Buy |
+11,000
| New | +$779K | ﹤0.01% | 5876 |
|
Other funds holding TRHC
Citadel Advisors's TRHC Position: Q4 2023 in Review
Citadel Advisors sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 296 shares — an estimated $3.05K sold.
Citadel Advisors first reported a position in TRHC in Q4 2017 and held it in 17 quarters. The position peaked at $5.11M in Q2 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Citadel Advisors reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 296 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $3.05K.
- Citadel Advisors first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
- Citadel Advisors's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $5.11M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.